Henrik Endeman - Concepedia

Author

Henrik Endeman

Also Known As

Dave A. Dongelmans, Endeman, Henrik, H Endeman, H Rik Endeman, H. (Rik) Endeman, H. Endeman, H., Endeman, Henrik Endeman, Karen C Bokhoven, R. Bierings

195

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam St. Antonius Ziekenhuis OLVG University Medical Center Utrecht

About

Henrik Endeman is an author at Erasmus MC specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	9.1K
2	Public Health	4	4	7.1K
3	Health Sciences	1	1	40
4	Allergy	1	1	34
5	Cardiothoracic Surgery	1	1	11

Henrik Endeman

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Frederikus A. Klok, Marieke J.H.A. Kruip, Nardo J. M. van der Meer, Thrombosis Research ThrombosisIll Icu PatientsClinical EpidemiologyPatient SafetyThrombotic Complications	2020	5.2K
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis Frederikus A. Klok, Marieke J.H.A. Kruip, Nardo J. M. van der Meer, Thrombosis Research ThrombosisCritical Care MedicineIll Icu PatientsClinical EpidemiologyPatient Safety	2020	1.6K
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, Science Immunology	2020	988
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij, Nature Communications	2021	830
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial Evelien de Jong, Jos A van Oers, Albertus Beishuizen, The Lancet Infectious Diseases Antibiotic TreatmentOpen-label TrialCritical Care MedicineAntimicrobial StewardshipAntibiotics	2016	789
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial Sabine C A Meijvis, Hans A Hardeman, Hilde HF Remmelts, The Lancet Community-acquired PneumoniaPatient SafetyHospital StayRespiratory InfectionInfectious Respiratory Disease	2011	362
Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants Jeroen J. A. van Kampen, David van de Vijver, Pieter L. A. Fraaij, Virus EpidemiologyViral DiagnosticsCovid-19 EpidemiologyCovid-19Viral Persistence	2020	254
Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) Alan Abdulla, Annemieke Dijkstra, Nicole Hunfeld, Critical Care	2020	133
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave Fleur H.J. Kaptein, Milou A.M. Stals, M. Grootenboers, Thrombosis Research	2020	125
Systemic cytokine response in patients with community-acquired pneumonia Henrik Endeman, Sabine C A Meijvis, Ger T. Rijkers, European Respiratory Journal InflammationCommunity-acquired PneumoniaCytokineAutoimmune DiseaseAntibiotics	2010	118

Page 1